Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: AstraZeneca
Breast Cancer · Biliary Tract Carcinoma · Ovarian Cancer · Endometrial Cancer
United States, Australia, Belgium, Canada, China +10 more
- A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled AsthmaActive Not Recruiting
Sponsor: GlaxoSmithKline
Asthma
United States, Bulgaria, Canada, Czechia, Germany +4 more
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)Active Not Recruiting
Sponsor: Longboard Pharmaceuticals
Developmental and Epileptic Encephalopathy
United States, Australia, Belgium, Brazil, Canada +12 more
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)Enrolling By Invitation
Sponsor: Longboard Pharmaceuticals
Developmental and Epileptic Encephalopathy
United States, Australia, Belgium, Brazil, China +9 more
- CHAMPION-AF Clinical TrialActive Not Recruiting
Sponsor: Boston Scientific Corporation
Atrial Fibrillation · Stroke · Bleeding
United States, Australia, Belgium, Canada, Denmark +11 more
Sponsor: Bristol-Myers Squibb
Alzheimer's Disease
United States, Argentina, Australia, Brazil, Finland +12 more
Sponsor: Immunovant Sciences GmbH
Graves' Disease
United States, Australia, Brazil, Bulgaria, Chile +12 more
Sponsor: AstraZeneca
Chronic Lymphocytic Leukaemia · Small Lymphocytic Lymphoma · Mantle-cell Lymphoma · Large B-cell Lymphoma
United States, Australia, China, Czechia, Denmark +8 more
Sponsor: Daiichi Sankyo
Advanced Solid Tumor · Metastatic Solid Tumor
United States, Belgium, Canada, China, France +3 more
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNot Yet Recruiting
Sponsor: AstraZeneca
Heart Failure With Preserved Ejection Fraction (HFpEF) · Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
United States, Argentina, Australia, Austria, Brazil +20 more
Sponsor: Crinetics Pharmaceuticals Inc.
Congenital Adrenal Hyperplasia · Classic Congenital Adrenal Hyperplasia
United States, Argentina, Australia, Austria, Brazil +9 more
Sponsor: Bayer
Advanced Non-small Cell Lung Cancer · EGFR Mutation · HER2 Mutation
United States, Belgium, Brazil, China, France +11 more
- A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With BronchiectasisRecruiting
Sponsor: GlaxoSmithKline
Bronchiectasis
United States, Argentina, China, Germany, Israel +7 more
- A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat StudyEnrolling By Invitation
Sponsor: Agios Pharmaceuticals, Inc.
Pyruvate Kinase Deficiency · Anemia, Hemolytic · Sickle Cell Disease · Thalassemia
Belgium, Brazil, Canada, France, Israel +3 more
Sponsor: Novartis Pharmaceuticals
Acute Coronary Syndrome
Argentina, Australia, Canada, China, France +9 more
Sponsor: UCB Biopharma SRL
Generalized Myasthenia Gravis
United States, Canada, France, Germany, Italy +5 more
- Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian CancerActive Not Recruiting
Sponsor: Genmab
Platinum-resistant Ovarian Cancer
United States, Australia, Austria, Belgium, Canada +13 more
- A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast CancerActive Not Recruiting
Sponsor: AstraZeneca
Breast Cancer
United States, Australia, Belgium, Canada, Denmark +13 more
Sponsor: Incyte Corporation
Unresectable Cholangiocarcinoma · Metastatic Cholangiocarcinoma
United States, Austria, Belgium, Canada, China +14 more
- Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With DurvalumabEnrolling By Invitation
Sponsor: AstraZeneca
Cancer
United States, Argentina, Australia, Belgium, Brazil +26 more
Sponsor: Tanabe Pharma America, Inc.
EPP · XLP
United States, Australia, Bulgaria, Canada, Czechia +10 more
Sponsor: Boehringer Ingelheim
Obesity
United States, Argentina, Australia, Austria, Belgium +30 more
Sponsor: Bristol-Myers Squibb
Alzheimer Disease
United States, Argentina, Brazil, Bulgaria, Canada +10 more
Sponsor: Amgen
Advanced Solid Tumors
United States, Australia, Canada, France, Japan +6 more
- A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)Active Not Recruiting
Sponsor: Eli Lilly and Company
Systemic Juvenile Idiopathic Arthritis
Argentina, Belgium, Brazil, Czechia, France +9 more